Co-Authors
This is a "connection" page, showing publications co-authored by JUAN FUEYO-MARGARETO and CANDELARIA GOMEZ-MANZANO.
Connection Strength
6.544
-
Gene therapy. Handb Clin Neurol. 2012; 104:331-8.
Score: 0.409
-
Oncolytic adenoviruses for the treatment of brain tumors. Curr Opin Mol Ther. 2010 Oct; 12(5):530-7.
Score: 0.375
-
Interspecies adenovirus fiber shows "evolutionary" advantage for oncolytic therapy of gliomas. Cancer Biol Ther. 2008 May; 7(5):794-6.
Score: 0.317
-
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan. Clin Cancer Res. 2006 Jan 15; 12(2):556-62.
Score: 0.271
-
Genetically modified adenoviruses against gliomas: from bench to bedside. Neurology. 2004 Aug 10; 63(3):418-26.
Score: 0.245
-
A novel E1A-E1B mutant adenovirus induces glioma regression in vivo. Oncogene. 2004 Mar 11; 23(10):1821-8.
Score: 0.238
-
[Molecular control of the cellular cycle and apoptosis: new treatments for gliomas]. Neurologia. 1998 Aug-Sep; 13(7):349-55.
Score: 0.161
-
Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination. Cancer Res. 2017 07 15; 77(14):3894-3907.
Score: 0.149
-
C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy. Oncogene. 2015 Oct 08; 34(41):5295-301.
Score: 0.126
-
Intratumoral heterogeneity and intraclonal plasticity: from warburg to oxygen and back again. Neuro Oncol. 2014 Aug; 16(8):1025-6.
Score: 0.122
-
Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model. PLoS One. 2014; 9(5):e97407.
Score: 0.120
-
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes. Oncotarget. 2014 Apr 30; 5(8):2208-20.
Score: 0.120
-
Targeting brain tumor stem cells with oncolytic adenoviruses. Methods Mol Biol. 2012; 797:111-25.
Score: 0.102
-
The E1B19K oncoprotein complexes with Beclin 1 to regulate autophagy in adenovirus-infected cells. PLoS One. 2011; 6(12):e29467.
Score: 0.102
-
Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype. Oncotarget. 2010 Dec; 1(8):700-709.
Score: 0.095
-
[Wernicke's encephalopathy in a female patient with the acquired immunodeficiency syndrome]. Med Clin (Barc). 1990 Dec 01; 95(19):754-5.
Score: 0.095
-
RB-E2F1: molecular rheostat for autophagy and apoptosis. Autophagy. 2010 Nov; 6(8):1216-7.
Score: 0.095
-
Advances in translational research in neuro-oncology. Arch Neurol. 2011 Mar; 68(3):303-8.
Score: 0.094
-
The RB-E2F1 pathway regulates autophagy. Cancer Res. 2010 Oct 15; 70(20):7882-93.
Score: 0.093
-
[Internuclear ophthalmoplegia related to opiate overdose]. Med Clin (Barc). 1990 Apr 28; 94(16):637.
Score: 0.091
-
Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas. Curr Gene Ther. 2009 Oct; 9(5):422-7.
Score: 0.087
-
Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters. Oncogene. 2009 Jun 18; 28(24):2358-63.
Score: 0.085
-
Autophagy pathways in glioblastoma. Methods Enzymol. 2009; 453:273-86.
Score: 0.083
-
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity. Cancer Gene Ther. 2009 Mar; 16(3):256-65.
Score: 0.082
-
VEGF Trap induces antiglioma effect at different stages of disease. Neuro Oncol. 2008 Dec; 10(6):940-5.
Score: 0.081
-
Tie2: a journey from normal angiogenesis to cancer and beyond. Histol Histopathol. 2008 06; 23(6):773-80.
Score: 0.080
-
E2F1 in gliomas: a paradigm of oncogene addiction. Cancer Lett. 2008 May 18; 263(2):157-63.
Score: 0.079
-
Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death. Mol Ther. 2008 Mar; 16(3):487-93.
Score: 0.078
-
Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. Cancer Res. 2007 Dec 15; 67(24):11499-504.
Score: 0.077
-
Adenovirus's last trick: you say lysis, we say autophagy. Autophagy. 2008 Jan; 4(1):118-20.
Score: 0.077
-
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst. 2007 Sep 19; 99(18):1410-4.
Score: 0.076
-
ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo. Cancer Res. 2007 Sep 01; 67(17):8255-63.
Score: 0.076
-
Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas. Oncogene. 2008 Feb 21; 27(9):1310-4.
Score: 0.076
-
Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo. Cancer Gene Ther. 2007 Aug; 14(8):756-61.
Score: 0.075
-
Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res. 2007 May 01; 67(9):4005-9.
Score: 0.074
-
Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol Cancer Res. 2006 Dec; 4(12):915-26.
Score: 0.072
-
Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas. Expert Rev Anticancer Ther. 2006 Nov; 6(11):1585-92.
Score: 0.071
-
A novel CRM1-dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylation. FASEB J. 2006 Dec; 20(14):2603-5.
Score: 0.071
-
E2F1 and telomerase: alliance in the dark side. Cell Cycle. 2006 May; 5(9):930-5.
Score: 0.069
-
Oncolytic adenoviruses as antiglioma agents. Expert Rev Anticancer Ther. 2006 May; 6(5):697-708.
Score: 0.069
-
Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth. Neoplasia. 2006 May; 8(5):419-28.
Score: 0.069
-
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst. 2005 Nov 02; 97(21):1589-600.
Score: 0.067
-
Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses. Neoplasia. 2005 Aug; 7(8):723-9.
Score: 0.066
-
Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Ther. 2005 Mar; 12(3):284-94.
Score: 0.064
-
Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas. Neoplasia. 2005 Jan; 7(1):48-56.
Score: 0.063
-
Robust infectivity and replication of Delta-24 adenovirus induce cell death in human medulloblastoma. Cancer Gene Ther. 2004 Nov; 11(11):713-20.
Score: 0.062
-
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst. 2003 May 07; 95(9):652-60.
Score: 0.056
-
Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Ann Neurol. 2003 Jan; 53(1):109-17.
Score: 0.055
-
Overexpression of E2F-1 leads to bax-independent cell death in human glioma cells. Int J Oncol. 2002 Nov; 21(5):1015-20.
Score: 0.054
-
Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2. Cancer Res. 2001 Sep 15; 61(18):6693-7.
Score: 0.050
-
Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU. Int J Oncol. 2001 Aug; 19(2):359-65.
Score: 0.050
-
[Oncolytic adenovirus for the treatment of cerebral tumors: past, present and future]. Neurologia. 2001 Mar; 16(3):122-7.
Score: 0.048
-
Co-expression of E2F-2 enhances the p53 anti-cancer effect in human glioma cells. Int J Oncol. 2001 Feb; 18(2):343-7.
Score: 0.048
-
Delivery of cell cycle genes to block astrocytoma growth. J Neurooncol. 2001 Feb; 51(3):277-87.
Score: 0.048
-
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene. 2000 Jan 06; 19(1):2-12.
Score: 0.045
-
Targeting in gene therapy for gliomas. Arch Neurol. 1999 Apr; 56(4):445-8.
Score: 0.042
-
Gene therapy for gliomas: p53 and E2F-1 proteins and the target of apoptosis. Int J Mol Med. 1999 Jan; 3(1):81-5.
Score: 0.042
-
The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies. Neurology. 1998 Nov; 51(5):1250-5.
Score: 0.041
-
Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat Med. 1998 Jun; 4(6):685-90.
Score: 0.040
-
Suppression of human glioma growth by adenovirus-mediated Rb gene transfer. Neurology. 1998 May; 50(5):1307-15.
Score: 0.040
-
Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy. Int J Oncol. 1998 Mar; 12(3):665-9.
Score: 0.039
-
Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J Natl Cancer Inst. 1997 Jul 16; 89(14):1036-44.
Score: 0.038
-
Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas. Oncogene. 1996 Oct 17; 13(8):1615-9.
Score: 0.036
-
Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res. 1996 Feb 15; 56(4):694-9.
Score: 0.034
-
Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene. 1996 Jan 04; 12(1):103-10.
Score: 0.034
-
Delta-24-RGD Induces Cytotoxicity of Glioblastoma Spheroids in Three Dimensional PEG Microwells. IEEE Trans Nanobioscience. 2015 Dec; 14(8):946-51.
Score: 0.034
-
A frequent polymorphism in exon 1 of the p16/CDKN2 gene. Mol Cell Probes. 1995 Dec; 9(6):465-6.
Score: 0.034
-
The oncolytic adenovirus ?24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity. J Bone Miner Res. 2014 Oct; 29(10):2287-96.
Score: 0.031
-
Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells. Br J Cancer. 2013 May 28; 108(10):2005-12.
Score: 0.028
-
Paraneoplastic syndromes. Neurology. 1993 Jan; 43(1):236.
Score: 0.027
-
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012 Apr; 8(4):445-544.
Score: 0.026
-
[Paraneoplastic encephalomyelitis and Lambert-Eaton syndrome]. Rev Neurol (Paris). 1992; 148(10):605-9.
Score: 0.026
-
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas. PLoS One. 2011; 6(11):e26740.
Score: 0.025
-
[Bezafibrate-induced necrotizing myopathy]. Med Clin (Barc). 1991 Mar 23; 96(11):439.
Score: 0.024
-
Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J Virol. 2011 May; 85(10):4720-9.
Score: 0.024
-
Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells. Cancer Gene Ther. 2010 Apr; 17(4):289-97.
Score: 0.022
-
Oncolytic adenoviruses for malignant glioma therapy. Front Biosci. 2003 May 01; 8:d577-88.
Score: 0.014
-
Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF. Br J Cancer. 2001 May 04; 84(9):1252-7.
Score: 0.012
-
Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses. Exp Cell Res. 1999 Oct 10; 252(1):1-12.
Score: 0.011
-
Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo. Cancer Res. 1999 Feb 15; 59(4):895-900.
Score: 0.010
-
Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro. Oncogene. 1997 Oct 23; 15(17):2049-57.
Score: 0.010